Simulations Plus, Inc. (Nasdaq: SLP) is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based biopharmaceutics/pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/...
Simulations Plus, Inc. (Nasdaq: SLP) is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based biopharmaceutics/pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.